Abstract

Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2012 - Volume 16, Number 2

Page(s): 155

Download in electronic PDF format for $75

Abstract

A formulation for preparing Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2012 Pg. 155	Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 234	Bupivacaine Hydrochloride 0.5% Injection Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 476	Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray Author(s): Allen Loyd V Jr
Jan/Feb 2002 Pg. 70-73	Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes Author(s): Trissel Lawrence A, Xu Quanyun A, Pham Lien
May/Jun 2008 Pg. 192-197	Compounded Local Anesthetics to Minimize Pain from Medical Procedures Author(s): McElhiney Linda F
May/Jun 2009 Pg. 218-219	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Mar/Apr 2024 Pg. 118-119	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024 Pg. 111-116	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Sep/Oct 1997 Pg. 325	Fentanyl-Bupivacaine-Epinephrine for Epidural Analgesia Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 520	Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 68	Mepivacaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
Nov/Dec 2007 Pg. 514-519	Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Author(s): Zugerman Jessie Jean M, Reed Thomas C
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
Jan/Feb 2018 Pg. 19-24	Pain: Systematic Review of Pharmacy Compounding of Pain Medication Author(s): Shawaqfeh Mohammad S, Harrington Catherine
Nov/Dec 2008 Pg. 540	Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr